Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Amicus Therapeutics (FOLD)

Amicus Therapeutics (FOLD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,846,924
  • Shares Outstanding, K 257,664
  • Annual Sales, $ 182,240 K
  • Annual Income, $ -356,390 K
  • 60-Month Beta 1.28
  • Price/Sales 20.43
  • Price/Cash Flow N/A
  • Price/Book 9.25

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.26
  • Number of Estimates 6
  • High Estimate -0.15
  • Low Estimate -0.33
  • Prior Year -0.34
  • Growth Rate Est. (year over year) +23.53%

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.10 +4.93%
on 07/31/20
16.13 -8.31%
on 07/13/20
-0.76 (-4.89%)
since 07/02/20
3-Month
10.48 +41.13%
on 06/12/20
16.13 -8.31%
on 07/13/20
+3.17 (+27.28%)
since 05/04/20
52-Week
6.25 +136.64%
on 03/16/20
16.13 -8.31%
on 07/13/20
+3.14 (+26.95%)
since 08/02/19

Most Recent Stories

More News
Amicus Therapeutics to Present at the BTIG Virtual Biotechnology Conference

Amicus Therapeutics (Nasdaq: FOLD) today announced that members of the Amicus senior leadership team will participate in a fireside chat at the BTIG Virtual Biotechnology Conference on Tuesday, August...

FOLD : 14.79 (-0.94%)
Will Amicus Therapeutics (FOLD) Report Negative Earnings Next Week? What You Should Know

Amicus Therapeutics (FOLD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

FOLD : 14.79 (-0.94%)
New Strong Sell Stocks for July 31st

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.

CME : 163.13 (+0.08%)
KAMN : 42.20 (+3.30%)
FOLD : 14.79 (-0.94%)
HAYN : 19.91 (+1.43%)
INDB : 63.52 (-0.90%)
Amicus Therapeutics to Announce Second Quarter 2020 Financial Results on August 10, 2020

Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Monday, August 10, 2020 at 8:30 a.m. ET to discuss financial results for the second...

FOLD : 14.79 (-0.94%)
Amicus Therapeutics Secures $400 Million Non-Dilutive Debt Financing

$400M Debt Facility Provides Path to Profitability Without the Need for Any Future Dilutive Financings

FOLD : 14.79 (-0.94%)
Watch for Amicus Therapeut to Potentially Rebound After Falling 3.86% Yesterday

Amicus Therapeut (NASDAQ:FOLD) traded in a range yesterday that spanned from a low of $14.16 to a high of $15.36. Yesterday, the shares fell 3.9%, which took the trading range below the 3-day low of...

FOLD : 14.79 (-0.94%)
Look for Shares of Amicus Therapeut to Potentially Pullback after Yesterday's 2.82% Rise

Amicus Therapeut (NASDAQ:FOLD) traded in a range yesterday that spanned from a low of $14.87 to a high of $15.70. Yesterday, the shares gained 2.8%, which took the trading range above the 3-day high...

FOLD : 14.79 (-0.94%)
Amicus Therapeut Rises 4.29% on Heavy Volume: Watch For Potential Pullback

Amicus Therapeut (NASDAQ:FOLD) traded in a range yesterday that spanned from a low of $12.77 to a high of $13.90. Yesterday, the shares gained 4.3%, which took the trading range above the 3-day high...

FOLD : 14.79 (-0.94%)
Why Is Amicus Therapeutics (FOLD) Up 10.9% Since Last Earnings Report?

Amicus Therapeutics (FOLD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

FOLD : 14.79 (-0.94%)
Amicus Therapeutics to Present at the Goldman Sachs 41st Annual Global Healthcare Conference

Amicus Therapeutics (Nasdaq: FOLD) today announced that John F. Crowley, Chairman and Chief Executive Officer, will participate in a fireside chat at the Goldman Sachs 41 Annual Global Healthcare Conference,...

FOLD : 14.79 (-0.94%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade FOLD with:

Business Summary

AMICUS THERAPEUTICS is a biopharmaceutical company developing novel, oral therapeutics known as pharmacological chaperones for the treatment of a range of human genetic diseases. Pharmacological chaperone technology involves the use of small molecules that selectively bind to and stabilizeproteins in...

See More

Key Turning Points

2nd Resistance Point 15.22
1st Resistance Point 15.01
Last Price 14.79
1st Support Level 14.56
2nd Support Level 14.32

See More

52-Week High 16.13
Last Price 14.79
Fibonacci 61.8% 12.36
Fibonacci 50% 11.19
Fibonacci 38.2% 10.02
52-Week Low 6.25

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar